Halozyme Therapeutics Inc (HALO)
38.46
-0.66
(-1.69%)
USD |
NASDAQ |
Apr 25, 16:00
38.46
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Stock Buybacks (Quarterly): 252.30M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 252.30M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 150.08M |
December 31, 2022 | 0.001M |
September 30, 2022 | 200.00M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 160.32M |
September 30, 2021 | 64.72M |
June 30, 2021 | 48.84M |
March 31, 2021 | 76.18M |
December 31, 2020 | 40.15M |
September 30, 2020 | 56.40M |
June 30, 2020 | 1.996M |
March 31, 2020 | 51.57M |
December 31, 2019 | 200.00M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.001M |
Date | Value |
---|---|
September 30, 2017 | -0.002M |
June 30, 2017 | -134.87M |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | -107.71M |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | -0.0002M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | -81.48M |
December 31, 2011 | 4.142M |
September 30, 2011 | -4.142M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
252.30M
Maximum
Dec 2023
68.56M
Average
48.84M
Median
Jun 2021
Stock Buybacks (Quarterly) Benchmarks
Johnson & Johnson | 216.00M |
Globus Medical Inc | 225.56M |
Denali Therapeutics Inc | -- |
AIM ImmunoTech Inc | -0.147M |
Protalix BioTherapeutics Inc | 0.00 |